News - Lymphoma Canada

News

The High Price Tag of an Innovative Treatment

The innovative drug ADCETRIS was approved for sale by Health Canada this past February.

adminMay 8, 2013

News

Treatment through positivity

When Hayley Holroyd looked into the mirror, she saw a healthy woman. It was not…

adminMay 8, 2013

Press Releases

Provincial drug plans adding new lymphoma treatment is good news for patients, but other promising cancer therapies still awaiting green light

TORONTO, April 24, 2013 /CNW/ - The recent approval by Health Canada of a highly…

adminMay 3, 2013

Press Releases

Lymphoma Foundation Canada announces name change and launch of new brand

TORONTO – April 29, 2013 Lymphoma Foundation Canada (LFC) has changed its name, logo and…

adminApril 29, 2013

Research

Obinutuzumab (GA101) Significantly Improved Progression-Free Survival in People With Chronic Lymphocytic Leukemia (CLL)

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced positive…

adminApril 25, 2013

Research

Health Canada Approves ADCETRIS®

“We are focused on making ADCETRIS available globally to all eligible patients with relapsed HL…

adminApril 25, 2013

Press Releases

Lymphoma Action Symposium with Richard Petit

MONTREAL, Nov. 1, 2012 /CNW Telbec/ - "Being diagnosed with a non-Hodgkin lymphoma at the…

adminApril 25, 2013

News

New Staff Announcement

On behalf of the Board of Directors of Lymphoma Canada, we would like to announce…

adminApril 11, 2013

Research

BC Cancer Agency Scientists Unlock Lymphoma Clues

Scientists studying lymphoma have mapped thousands of genes and decoded the entire genome of a…

adminApril 11, 2013

Research

Cancer Advocacy Coalition of Canada (CAC) releases the 2010-2011 Report Card on Cancer in Canada

ANNUAL REPORT CARD ON CANCER IN CANADA(TM) REVEALS CANADIANS FIGHTING CANCER ON TWO FRONTS: THE…

adminApril 11, 2013

Mon	Tue	Wed	Thu	Fri	Sat	Sun
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

News & Media

The High Price Tag of an Innovative Treatment

Treatment through positivity

Provincial drug plans adding new lymphoma treatment is good news for patients, but other promising cancer therapies still awaiting green light

Lymphoma Foundation Canada announces name change and launch of new brand

Obinutuzumab (GA101) Significantly Improved Progression-Free Survival in People With Chronic Lymphocytic Leukemia (CLL)

Health Canada Approves ADCETRIS®

Lymphoma Action Symposium with Richard Petit

New Staff Announcement

BC Cancer Agency Scientists Unlock Lymphoma Clues

Cancer Advocacy Coalition of Canada (CAC) releases the 2010-2011 Report Card on Cancer in Canada

Are you a patient?

Are you a healthcare professional?

Upcoming Events

Contact Us

Donate

Join Our Mailing List